Dong Xue
Research Subjects
Research Interests
Dong Xue has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
Cang Shundong
1 shared publicationCao Li
1 shared publicationCao Yanshuo
1 shared publicationChen Bailin
1 shared publicationChen Chaowu
1 shared publicationChen Jun
1 shared publication
Latest Publications
- Open Access
- 5 February 2026
- Published by Springer Nature in Holistic Integrative Oncology
- Vol. 5 (1)
CACA guidelines for holistic integrative management of older adults with cancer
This guideline aims to provide evidence-based recommendations for the prevention, screening, assessment, diagnosis, treatment decision, and survivorship care of older adults with cancer. The CACA Geriatric Oncology Society convened expert panels to plan, write, and revise the manuscript. These experts engaged in in-depth discussions to propose clinical practice recommendations for geriatric oncology. The guideline highlights the increasing prevalence and mortality of cancer among the older adults in China, driven by an aging population. It emphasizes that a comprehensive geriatric assessment is critical for optimal treatment decision-making. Additionally, the use of traditional Chinese Medicine is suggested to minimize toxicity, alleviate symptoms, and enhance immune function. In conclusion, integrative and multidisciplinary approaches are essential to achieving both increased longevity and improved quality of life for older patients with cancer.
- 5 February 2026
- Published by Springer Nature in Holistic Integrative Oncology
- Vol. 5 (1)
Open AccessCACA guidelines for holistic integrative management of older adults with cancer
This guideline aims to provide evidence-based recommendations for the prevention, screening, assessment, diagnosis, treatment decision, and survivorship care of older adults with cancer. The CACA Geriatric Oncology Society convened expert panels to plan, write, and revise the manuscript. These experts engaged in in-depth discussions to propose clinical practice recommendations for geriatric oncology. The guideline highlights the increasing prevalence and mortality of cancer among the older adults in China, driven by an aging population. It emphasizes that a comprehensive geriatric assessment is critical for optimal treatment decision-making. Additionally, the use of traditional Chinese Medicine is suggested to minimize toxicity, alleviate symptoms, and enhance immune function. In conclusion, integrative and multidisciplinary approaches are essential to achieving both increased longevity and improved quality of life for older patients with cancer.